2,842
edits
Depression: Difference between revisions
m
no edit summary
mNo edit summary |
mNo edit summary |
||
| Line 14: | Line 14: | ||
# '''Reducing overstimulation''' - anti rumination, reduce caffeine intake, increase mindfulness and meditation practices. | # '''Reducing overstimulation''' - anti rumination, reduce caffeine intake, increase mindfulness and meditation practices. | ||
# '''Talking''' - self therapy, counselling, increase social contact. | # '''Talking''' - self therapy, counselling, increase social contact. | ||
The next step would be to consider an antidepressant. Doctors often prescribe the SSRI, fluoxetine as the first port of call however, statistically, they (and all other antidepressants) are only effective by a small margin. It has been found that 54% of adults experience a reduction in symptoms after taking an antidepressant, however 35–40% experience similar improvements after taking a [[placebo]]. This means antidepressants are only responsible for a decrease in symptoms of around 20%<ref>'''Treatment outcomes for depression: challenges and opportunities.''' Pim Cuijpers, Argyris Stringaris, Miranda Wolpert. Published in the Lancet Psychiatry: February 17, 2020. Accessed on 31 March 2023 via DOI:<nowiki>https://doi.org/10.1016/S2215-0366(20)30036-5</nowiki></ref>. To compound this, the 20% who see some effectiveness are plagued by the fact that about a third of these symptoms return at some point during therapy. | The next step would be to consider an [[Antidepressants|antidepressant]]. Doctors often prescribe the SSRI, fluoxetine as the first port of call however, statistically, they (and all other antidepressants) are only effective by a small margin. It has been found that 54% of adults experience a reduction in symptoms after taking an antidepressant, however 35–40% experience similar improvements after taking a [[placebo]]. This means [[antidepressants]] are only responsible for a decrease in symptoms of around 20%<ref>'''Treatment outcomes for depression: challenges and opportunities.''' Pim Cuijpers, Argyris Stringaris, Miranda Wolpert. Published in the Lancet Psychiatry: February 17, 2020. Accessed on 31 March 2023 via DOI:<nowiki>https://doi.org/10.1016/S2215-0366(20)30036-5</nowiki></ref>. To compound this, the 20% who see some effectiveness are plagued by the fact that about a third of these symptoms return at some point during therapy. | ||
=== Relapse === | === Relapse === | ||